SCOPUS 정보 검색 플랫폼

Volumn 62, Issue 3, 2002, Pages 216-222

Phase I study of paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) administered every 2 weeks in patients with advanced solid tumors

(9) Mavroudis, Dimitris a Kouroussis, Ch a Kakolyris, S a Agelaki, S a Kalbakis, K a Androulakis, N a Souglakos, J a Samonis, G a Georgoulias, V a

a UNIVERSITY HOSPITAL OF HERAKLION (Greece)

Author keywords

Liposomal doxorubicin; Paclitaxel; Phase I; Solid tumors

Indexed keywords

DOXORUBICIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG TOLERANCE; EVALUATION; HEART ARREST; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; NAUSEA; NEUTROPENIA; PATIENT CARE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SOLID TUMOR; THROMBOCYTOPENIA; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LIPOSOMES; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASMS; PACLITAXEL; POLYETHYLENE GLYCOLS; SURVIVAL RATE;

EID: 0036279089 PISSN: 00302414 EISSN: None Source Type: Journal
DOI: 10.1159/000059568 Document Type: Article

Times cited : (28)

References (25)

1
- 0028877036
- Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: High antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study
- (1995) J Clin Oncol , vol.13 , pp. 2688-2699
- Gianni, L.¹ Munzone, E.² Capri, G.³ Fulfaro, F.⁴ Tarenzi, E.⁵ Villani, F.⁶ Spreafico, C.⁷ Laffranchi, A.⁸ Caraceni, A.⁹ Martini, C.¹⁰

2
- 0029786845
- Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic
- (1996) Ann Oncol , vol.7 , pp. 687-693
- Gehl, J.¹ Boesgaard, M.² Paaske, T.³ Vittrup Jensen, B.⁴ Dombernowsky, P.⁵

3
- 0032760998
- Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: An Eastern Cooperative Oncology Group Study
- (1999) J Clin Oncol , vol.17 , pp. 3828-3834
- Sparano, J.A.¹ Hu, P.² Rao, R.M.³ Falkson, C.I.⁴ Wolff, A.C.⁵ Wood, W.C.⁶

4
- 10144261886
- Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel and doxorubicin in patients with metastatic breast cancer
- (1996) J Clin Oncol , vol.14 , pp. 2713-2721
- Holmes, F.A.¹ Madden, T.² Newman, R.A.³ Valero, V.⁴ Theriault, R.L.⁵ Fraschini, G.⁶ Walters, R.S.⁷ Booser, D.J.⁸ Buzdar, A.U.⁹ Willey, J.¹⁰ Hortobagyi, G.N.¹¹

5
- 0030977999
- Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer
- (1997) J Clin Oncol , vol.15 , pp. 1906-1915
- Gianni, L.¹ Vigano, L.² Locatelli, A.³ Capri, G.⁴ Giani, A.⁵ Tarenzi, E.⁶ Bonadonna, G.⁷

6
- 0032907443
- Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin
- (1999) Ann Oncol , vol.10 , pp. 391-395
- Colombo, T.¹ Parisi, I.² Zucchetti, M.³ Sessa, C.⁴ Goldhirsch, A.⁵ D'Incalci, M.⁶

7
- 0029009612
- Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer
- (1995) Semin Oncol , vol.22 , Issue.3 SUPPL. 6 , pp. 105-108
- Sledge, G.W.¹ Robert, N.² Sparano, J.A.³ Cogleigh, M.⁴ Goldstein, L.J.⁵ Neuberg, D.⁶ Rowinsky, E.⁷ Baughman, C.⁸ McCaskill-Stevens, W.⁹

8
- 0028324859
- Pharmacokinetics, biodistribution and therapeutic efficacy of doxorubicin encapsulated in Stealth liposomes (Doxil)
- (1994) J Liposom Res , vol.4 , pp. 667-687
- Working, P.K.¹ Newsman, M.S.² Huang, S.K.³

9
- 0026352832
- Sterically stabilized liposomes: Improvement in pharmacokinetics and antitumor therapeutic efficacy
- (1991) Proc Natl Acad Sci USA , vol.88 , pp. 11460-11464
- Papahadjopoulos, D.¹ Allen, T.² Gabizon, A.³ Mayhew, E.⁴ Matthay, K.⁵ Huang, S.K.⁶ Lee, K.D.⁷ Woodle, M.C.⁸ Lasik, D.D.⁹ Redemann, C.¹⁰

10
- 0030959798
- Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: Results of a multicenter phase II trial
- (1997) J Clin Oncol , vol.15 , pp. 3185-3191
- Ranson, M.R.¹ Carmichael, J.² O'Byrne, K.³ Stewart, S.⁴ Smith, D.⁵ Howell, A.⁶

11
- 0031055830
- Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation
- (1997) J Clin Oncol , vol.15 , pp. 987-993
- Muggia, F.M.¹ Hainsworth, J.D.² Jeffers, S.³ Miller, P.⁴ Groshen, S.⁵ Tan, M.⁶ Roman, L.⁷ Uziely, B.⁸ Muderspach, L.⁹ Garcia, A.¹⁰ Burnett, A.¹¹ Greco, F.A.¹² Morrow, C.P.¹³ Paradiso, L.J.¹⁴ Liang, L.J.¹⁵

12
- 0031036426
- Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy
- (1997) J Clin Oncol , vol.15 , pp. 653-659
- Northfelt, D.W.¹ Dezube, B.J.² Thommes, J.A.³ Levine, R.⁴ Von Roenn, J.H.⁵ Dosil, G.M.⁶ Rios, A.⁷ Krown, S.E.⁸ DuMond, C.⁹ Mamelok, R.D.¹⁰

13
- 0029038996
- Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies
- (1995) J Clin Oncol , vol.13 , pp. 1777-1785
- Uziely, B.¹ Jeffers, S.² Isacson, R.³ Kutsch, K.⁴ Wei-Tsao, D.⁵ Yehoshua, Z.⁶ Libson, E.⁷ Muggia, F.M.⁸ Gabizon, A.⁹

14
- 0019365237
- Reporting results of cancer treatment
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹ Hoogstraten, B.B.² Staquet, M.³ Winkler, A.⁴

15
- 0033168435
- Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes
- (1999) Cancer , vol.86 , pp. 72-78
- Symon, Z.¹ Peyser, A.² Tzemach, D.³ Lyass, O.⁴ Sucher, E.⁵ Shezen, E.⁶ Gabizon, A.⁷

16
- 0030827548
- The biodistribution and pharmacokinetics of stealth liposomes in patients with solid tumors
- (1997) Oncology , vol.10 , pp. 33-37
- Stewart, S.¹ Harrington, K.J.²

17
- 0030719934
- Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors
- (1997) Cancer Res , vol.57 , pp. 5246-5253
- Krishna, R.¹ Mayer, L.D.²

18
- 0030660141
- Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers
- (1997) Drugs , vol.54 , Issue.SUPPL. 4 , pp. 22-29
- Muggia, F.M.¹

19
- 0030669086
- Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours
- (1997) Drugs , vol.54 , Issue.SUPPL. 4 , pp. 15-21
- Gabizon, A.¹ Martin, F.²

20
- 0032958460
- Relationship of dose intensity to the induction of palmar-plantar erythrodysesthesia by pegylated liposomal doxorubicin in dogs
- (1999) Hum Exp Toxicol , vol.18 , pp. 17-26
- Amantea, M.¹ Newman, M.S.² Sullivan, T.M.³ Forrest, A.⁴ Working, P.K.⁵

21
- 0030657658
- Doxorubicin plus paclitaxel in advanced breast cancer
- (1997) Semin Oncol , vol.24 , Issue.5 SUPPL. 17 , pp. 15-18
- Dombernowsky, P.¹ Boesgaard, M.² Andersen, E.³ Jensen, B.V.⁴

22
- 0002528999
- Phase II randomised trial of doxorubicin plus paclitaxel (AT) versus doxorubicin HCL liposome injection (Doxil) plus paclitaxel (DT) in metastatic breast cancer
- abstr 614
- (1998) Proc Am Soc Clin Oncol , vol.17
- Moore, M.R.¹ Srinivasiah, J.² Feinberg, B.A.³ Bordoni, R.E.⁴ Lesesne, J.B.⁵ Carr, D.⁶ Spinolo, J.⁷ Galleshaw, J.⁸ Moseley, L.⁹ Lefler, J.¹⁰ McKenzie, P.¹¹

23
- 0000224494
- 2 cumulative doses of Doxil
- abstr 804
- (2000) Proc Am Soc Clin Oncol , vol.19
- Safra, T.¹ Muggia, F.² Jeffers, S.³ Groshen, S.⁴ Tsao-Wei, D.⁵ Angeles, A.⁶ Lyass, O.⁷ Henderson, R.W.⁸ Berry, G.⁹ Gabizon, A.¹⁰

24
- 0033999408
- Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer
- (2000) Ann Oncol , vol.11 , pp. 339-342
- Caponigro, F.¹ Comella, P.² Budillon, A.³ Bryce, J.⁴ Avallone, A.⁵ De Rosa, V.⁶ Ionna, F.⁷ Comella, G.⁸

25
- 4243280544
- Activity of pegylated liposomal doxorubicin (Caelyx) advanced transitional cell carcinoma
- abstr 1431
- (2000) Proc Am Soc Clin Oncol , vol.19
- Ernst, D.S.¹ Winquist, E.² Moore, M.³ Jonker, D.⁴ Friel, C.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.